Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 Jun 1;12(11):1662-3.
doi: 10.4161/cc.25072. Epub 2013 May 17.

Progestins: pro-senescence therapy for ovarian cancer?

Affiliations
Comment

Progestins: pro-senescence therapy for ovarian cancer?

Steffi Oesterreich et al. Cell Cycle. .
No abstract available

Keywords: FOXO1; immune therapy; ovarian cancer; progesterone; senescence.

PubMed Disclaimer

Figures

None
Figure 1. Schematic representation of PR action as target in different subtypes of ovarian cancer. SMS, senescence messaging secretome.

Comment on

References

    1. Modugno F, Laskey R, Smith AL, Andersen CL, Haluska P, Oesterreich S. Hormone response in ovarian cancer: time to reconsider as a clinical target? Endocr Relat Cancer. 2012;19:R255–79. doi: 10.1530/ERC-12-0175. - DOI - PMC - PubMed
    1. Diep CH, Charles NJ, Gilks CB, Kalloger SE, Argenta PA, Lange CA. Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells. Cell Cycle. 2013;12:1433–49. doi: 10.4161/cc.24550. - DOI - PMC - PubMed
    1. Zheng H, Kavanagh JJ, Hu W, Liao Q, Fu S. Hormonal therapy in ovarian cancer. Int J Gynecol Cancer. 2007;17:325–38. doi: 10.1111/j.1525-1438.2006.00749.x. - DOI - PubMed
    1. Langdon SP, Gabra H, Bartlett JM, Rabiaz GJ, Hawkins RA, Tesdale AL, et al. Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen. Clin Cancer Res. 1998;4:2245–51. - PubMed
    1. Kuilman T, Peeper DS. Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer. 2009;9:81–94. doi: 10.1038/nrc2560. - DOI - PubMed

Substances